
Recently, demand for medications like Ozempic, Wegovy, or Mounjaro, including their off-label use, has skyrocketed in the wake of enthusiastic celebrity endorsements.
Bernard Esquivel, MD, PhD serves as the Head of Clinical Innovation for ixlayer, a digital health company building the future of healthcare - starting with health testing. A healthcare industry veteran with more than a decade of experience driving innovations in the healthcare space, Esquivel has deep knowledge and experience in various domains, from genomics and precision medicine to population health management and digital health. His career has been laser focused on making precision medicine and digital health a reality, overcoming challenges to make it clinically actionable and cost-effective.

Recently, demand for medications like Ozempic, Wegovy, or Mounjaro, including their off-label use, has skyrocketed in the wake of enthusiastic celebrity endorsements.

Published: July 10th 2023 | Updated: